Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

INTRODUCTION: Apalutamide and enzalutamide are next-generation androgen receptor inhibitors that demonstrated efficacy in placebo-controlled studies (SPARTAN for apalutamide; PROSPER for enzalutamide) when used in combination with androgen deprivation therapy (ADT) for treatment of non-metastatic ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Simon, Oudard, Stéphane, Uemura, Hiroji, Joniau, Steven, Pilon, Dominic, Ladouceur, Martin, Behl, Ajay S., Liu, Jinan, Dearden, Lindsay, Sermon, Jan, Van Sanden, Suzy, Diels, Joris, Hadaschik, Boris A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979453/
https://www.ncbi.nlm.nih.gov/pubmed/31813086
http://dx.doi.org/10.1007/s12325-019-01156-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6979453/
https://www.ncbi.nlm.nih.gov/pubmed/31813086
http://dx.doi.org/10.1007/s12325-019-01156-5

Ejemplares similares